Adam Kole

Adam Kole
Assistant Professor

Year	Title	Altmetric
2020	Outcomes, Prognostic Factors and Salvage Treatment for Recurrent Chordoma After Pencil Beam Scanning Proton Therapy at the Paul Scherrer Institute 2020
2019	Overall survival is improved when DCIS accompanies invasive breast cancer 2019
2018	Early assessment of lung cancer immunotherapy response via circulating tumor DNA 2018
2017	Acute radiation dermatitis in breast cancer patients: Challenges and solutions 2017
2017	Predictors of nonadherence to NCCN guideline recommendations for the management of stage i anal canal cancer 2017
2016	Concurrent chemoradiotherapy versus radiotherapy alone for “biopsy-only” glioblastoma multiforme 2016
2014	The E3 ligase PARC mediates the degradation of cytosolic cytochrome c to promote survival in neurons and cancer cells 2014
2013	Mature neurons: equipped for survival. 2013
2011	miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis 2011
2011	Activation of apoptosis by cytoplasmic microinjection of cytochrome c. 2011
2004	Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance 2004

Year	Title	Altmetric
2016	Early Stage Breast Cancer 2016
2016	Locally Advanced Breast Cancer 2016
2014	Neuronal death mechanisms in development and disease. 167-188. 2014

UAB NRG Oncology Master Institution Purchased Service Agreement awarded by NRG ONCOLOGY FOUNDATION 2019

Doctor of Medicine, University of North Carolina at Chapel Hill 2013

Doctor of Philosophy in Medical Cell Biology, University of North Carolina at Chapel Hill 2011

Bachelor of Arts in Chemistry, Duke University 2004

Adam Kole